financetom
Business
financetom
/
Business
/
Boeing's Outlook Dependent on Strike Resolution; Company Sees `Significantly Better' Cash Flow in 2025
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Boeing's Outlook Dependent on Strike Resolution; Company Sees `Significantly Better' Cash Flow in 2025
Oct 25, 2024 9:12 AM

11:44 AM EDT, 10/25/2024 (MT Newswires) -- Boeing's ( BA ) fortunes depend on resolving a labor dispute with striking workers with the world's largest aircraft manufacturer expected to continue burning cash in the fourth quarter before rebounding in the second half of 2025.

The Arlington, Virginia-based company on Wednesday reported a Q3 net loss of $6.17 billion, free cash flow loss of $1.96 billion and an operating cash flow loss of $1.35 billion, partly reflecting "unfavorable working capital timing," including the impact of a strike by the International Association of Machinists and Aerospace Worker.

Boeing ( BA ) expects fourth-quarter free cash flow to come in around the second-quarter loss of $4.33 billion before becoming "significantly better" in late 2025, Chief Financial Officer Brian West said on the earnings call.

The timing depends on how quickly the strike ends, Jeff Windau, a senior equity analyst at Edward Jones, said in an interview.

Boeing's ( BA ) latest offer this week included a 35% wage increase over four years, up from 25% previously; a $7,000 ratification bonus for all employees; and an increase of the 401(k) match to 100% from 75%, as well as a one-time contribution of $5,000 to all employee accounts. The proposal failed to mention a revival of a pension program, a point of contention for the strikers, said Chris Olin, an equity analyst at Northcoast Research.

"They were talking negative free cash flow in the first half, but that might start to bleed into the second half of the year if they don't come to a resolution in a relatively expedient time period," Windau said.

Price: 155.07, Change: -0.13, Percent Change: -0.09

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
XTL Biopharmaceuticals to Acquire 85% Stake in Beyond Air's NeuroNOS
XTL Biopharmaceuticals to Acquire 85% Stake in Beyond Air's NeuroNOS
Mar 11, 2026
07:56 AM EST, 01/13/2026 (MT Newswires) -- XTL Biopharmaceuticals (XTLB) said Wednesday it will acquire an 85% stake in NeuroNOS, a subsidiary of Beyond Air ( XAIR ) . Under the agreement, the company said it will pay $1 million in cash, 19.9% of its issued share capital, and make milestone-based payments of up to $32.5 million, including $5.5 million...
RBC, Canadian Tire, Launch Loyalty Partnership
RBC, Canadian Tire, Launch Loyalty Partnership
Mar 11, 2026
07:57 AM EST, 01/13/2026 (MT Newswires) -- Royal Bank of Canada ( RY ) and Canadian Tire (CTC-A.TO) Tuesday launched their loyalty partnership, to expand the reach of Triangle Rewards and strengthen RBC's Avion Rewards and its network of merchant partners. RBC cardholders can earn 3x Canadian Tire Money when they use their RBC credit or debit card that has...
Form 8.3
Form 8.3
Mar 11, 2026
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of...
Oramed and Lifeward Announce Strategic Transaction
Oramed and Lifeward Announce Strategic Transaction
Mar 11, 2026
Transaction Will Transfer Oramed's Oral Drug Delivery Platform (POD™ Technology) to Lifeward ( LFWD ) and Positions Oramed as a Significant Shareholder Oramed will transfer POD™ platform to Lifeward ( LFWD ) while retaining management of clinical programOramed will receive 49.9% beneficial ownership interest in Lifeward ( LFWD ), a revenue-generating medical robotics company, including warrantsMark Grant, Lifeward ( LFWD )...
Copyright 2023-2026 - www.financetom.com All Rights Reserved